Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 10 (Search time: 0.006 seconds).
  • previous
  • 1
  • next

  CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980 (Journal article)

  Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells (Journal article)

  Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival (Journal article)

  Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines (Journal article)

  A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo (Journal article)

  Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades (Journal article)

  Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells (Journal article)

  Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas (Journal article)

  Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas (Journal article)

  Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy (Journal article)